Health Tip to Prevent Stroke in Atrial Fibrillation

Newer drugs called direct oral anticoagulants which include edoxaban, apixaban, rivaroxaban and dabigatran have been approved by the US Food and Drug Administration (USFDA) for the treatment of non-valvular atrial fibrillation. A review on the use of the drugs for the purpose was published in the US Pharmacist.

Related Links